C. Crandall

发表

Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation

C. Derby, C. Crandall, R. Thurston, 2010, Climacteric : the journal of the International Menopause Society.

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide

C. Crandall, D. Ganz, Takahiro Mori, 2019, JBMR plus.

Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.

J. Manson, J. Cauley, P. Newcomb, 2017, Obstetrics and gynecology.

Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis : Update of a 2007 Report Executive Summary

P. Shekelle, Y. Lim, C. Crandall, 2012 .

Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA

C. Crandall, D. Ganz, T. Mori, 2017, Osteoporosis International.

Bone resorption and fracture across the menopausal transition: the Study of Women’s Health Across the Nation

J. Cauley, L. Meyn, G. Greendale, 2012, Menopause.

Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative

Mathew D. Sorensen, L. Carbone, N. Watts, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Estradiol and Follicle‐Stimulating Hormone as Predictors of Onset of Menopause Transition‐Related Bone Loss in Pre‐ and Perimenopausal Women

J. Cauley, G. Greendale, C. Crandall, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period.

C. Tseng, G. Greendale, C. Crandall, 2013, The Journal of clinical endocrinology and metabolism.

Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

J. Sinsheimer, S. Crawford, L. Habel, 2009, Breast Cancer Research.

Treatment of Vulvovaginal Atrophy.

C. Crandall, 2019, JAMA.

Management of Menopausal Symptoms: A Review.

J. Manson, C. Crandall, Jaya M Mehta, 2023, JAMA.

Safety of vaginal estrogens: a systematic review.

C. Crandall, N. Santoro, A. Diamant, 2020, Menopause.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

J. Manson, J. Cauley, R. Chlebowski, 2017, Menopause.

Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, J. Wactawski‐Wende, 2017, The Journal of clinical endocrinology and metabolism.

The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, J. Wactawski‐Wende, 2017, The American journal of clinical nutrition.

Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures.

A. LaCroix, J. Cauley, J. Robbins, 2021, JAMA internal medicine.

Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross‐Sectional Survey

C. Crandall, K. Mara, P. Schnatz, 2019, Mayo Clinic proceedings.

Update in Women's Health: Evidence Published in 2013

C. Crandall, J. Pregler, C. Crandall, 2014, Annals of Internal Medicine.

Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.

C. Crandall, C. Crandall, 2003, Journal of women's health.

Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk

J. Papp, E. Sobel, Zuo-Feng Zhang, 2017, Breast Cancer Research and Treatment.

Obesity and associated lifestyles modify the effect of glucose metabolism‐related genetic variants on impaired glucose homeostasis among postmenopausal women

J. Papp, E. Sobel, Zuo-Feng Zhang, 2016, Genetic epidemiology.

Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.

Huiyong Zheng, John F Randolph, S. Crawford, 2011, The Journal of clinical endocrinology and metabolism.

Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

J. Manson, W. Willett, F. Grodstein, 2019, Menopause.

Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal

K. Ensrud, S. Reed, C. Crandall, 2022, JAMA network open.

Impact of Body Weight Dynamics Following Intentional Weight Loss on Fracture Risk: Results from The Action for Health in Diabetes Study

C. Lewis, S. Kritchevsky, R. Casanova, 2018, JBMR plus.

Narrative Review: Hyperkyphosis in Older Persons

C. Crandall, D. Kado, K. Prenovost, 2007, Annals of Internal Medicine.

K. Matthews, S. Crawford, E. Gold, 2013, American journal of epidemiology.

Genetic variation and hot flashes: A systematic review.

J. Sinsheimer, M. Maglione, C. Crandall, 2020, The Journal of clinical endocrinology and metabolism.

Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review.

E. Barrett-Connor, C. Crandall, C. Crandall, 2013, Endocrinology and metabolism clinics of North America.

Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials.

K. Ensrud, S. Reed, C. Crandall, 2022, Maturitas.

The Women's Health Initiative: A Landmark Resource for Skeletal Research Since 1992

J. Cauley, C. Crandall, C. Crandall, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.

S. Crawford, C. Derby, C. Crandall, 2019, Menopause.

Knowledge and Needs of Resident Physicians Regarding Osteoporosis: A Nationwide Survey of Residents

D. Bauer, D. Elashoff, C. Crandall, 2021, JBMR plus.

After the initial fracture in postmenopausal women, where do subsequent fractures occur?

A. LaCroix, J. Cauley, J. Robbins, 2021, EClinicalMedicine.

Association between post-stroke disability and 5-year hip-fracture risk: The Women's Health Initiative.

K. Ensrud, K. Lakshminarayan, K. Margolis, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.

L. Carbone, N. Watts, K. Ensrud, 2020, JAMA internal medicine.

Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women’s Health Initiative Study

J. Manson, A. LaCroix, J. Cauley, 2018, Journal of General Internal Medicine.

Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing

J. Cauley, K. Ensrud, B. Taylor, 2017, Journal of General Internal Medicine.

Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.

A. LaCroix, K. Ensrud, J. Fine, 2017, The American journal of medicine.

Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.

J. Manson, J. Cauley, J. Wactawski‐Wende, 2015, The Journal of clinical endocrinology and metabolism.

Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review

C. Crandall, C. Crandall, 2015, Current Osteoporosis Reports.

Baseline age and time to major fracture in younger postmenopausal women

A. LaCroix, K. Ensrud, J. Fine, 2015, Menopause.

Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures

P. Shekelle, Y. Lim, W. Gellad, 2014, Annals of Internal Medicine.

Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.

A. LaCroix, J. Cauley, J. Robbins, 2014, The Journal of clinical endocrinology and metabolism.

Osteoporosis Screening in Postmenopausal Women 50 to 64 Years Old: Comparison of US Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative

A. LaCroix, J. Cauley, J. Robbins, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Marital histories, marital support, and bone density: findings from the Midlife in the United States Study

T. Seeman, G. Greendale, C. Crandall, 2014, Osteoporosis International.

Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative

Jennifer G. Robinson, J. Manson, C. Crandall, 2021, Menopause.

C‐Reactive Protein, Bone Strength, and Nine‐Year Fracture Risk: Data From the Study of Women's Health Across the Nation (SWAN)

J. Cauley, Y. Ouchi, G. Greendale, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Air pollution and decreased bone mineral density among Women's Health Initiative participants

A. Baccarelli, I. Ionita-Laza, D. Liao, 2023, EClinicalMedicine.

Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN)

G. Greendale, C. Crandall, Mei-hua Huang, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

M. Pike, B. Reboussin, G. Ursin, 2005, American journal of epidemiology.

Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study

J. Cauley, J. Wactawski‐Wende, C. Crandall, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Previous fracture and subsequent fracture risk: A meta-analysis to update FRAX

D. Kiel, V. Gudnason, A. Díez-Pérez, 2023, Osteoporosis International.

Sodium Intake and Osteoporosis. Findings From the Women's Health Initiative.

R. Prentice, L. Carbone, J. Wactawski‐Wende, 2016, The Journal of clinical endocrinology and metabolism.

Socioeconomic status, race, and bone turnover in the Midlife in the US Study

T. Seeman, G. Greendale, C. Crandall, 2012, Osteoporosis International.

History of socioeconomic disadvantage and allostatic load in later life.

T. Seeman, C. Crandall, T. Gruenewald, 2012, Social science & medicine.

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan

D. Kiel, S. Cummings, O. Bruyère, 2022, Osteoporosis International.

Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials

A. LaCroix, J. Cauley, J. Robbins, 2019, JBMR plus.

Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.

E. Barrett-Connor, B. Reboussin, D. Herrington, 2006, The American journal of medicine.

Vasomotor symptoms and accelerated epigenetic aging in the Women's Health Initiative (WHI).

M. Levine, S. Horvath, L. Hou, 2020, The Journal of clinical endocrinology and metabolism.

Genomic insights into the mechanism of NK3R antagonists for treatment of menopausal vasomotor symptoms

K. Ruth, C. Crandall, A. Murray, 2022, medRxiv.

Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study

S. Horvath, J. Manson, J. Sinsheimer, 2017, Menopause.

Quality Indicators for the Screening and Care of Urinary Incontinence in Vulnerable Elders

C. Crandall, C. Fung, B. Spencer, 2007, Journal of the American Geriatrics Society.

Characteristics of Self‐Reported Sleep and the Risk of Falls and Fractures: The Women's Health Initiative (WHI)

J. Cauley, K. Stone, K. Barbour, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries

Ivana V. Yang, Zhaohui S. Qin, Andrew D. Johnson, 2018, Nature Communications.

An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels

Ivana V. Yang, Andrew D. Johnson, Ryan D. Hernandez, 2018, Circulation.

Vasomotor symptoms and insulin resistance in the study of women's health across the nation.

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2012, The Journal of clinical endocrinology and metabolism.

Vasomotor Symptoms and Lipid Profiles in Women Transitioning Through Menopause

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2012, Obstetrics and gynecology.

Association of sleep disturbance and sexual function in postmenopausal women

Emily W. Gower, J. Manson, C. Crandall, 2017, Menopause.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2)

T. Wilt, E. Balk, T. Shamliyan, 2023, Annals of Internal Medicine.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition

D. Kiel, C. Cooper, M. Hochberg, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Study of Women's Health Across the Nation

K. Matthews, B. Sternfeld, E. Gold, 2009 .

Laboratory workup for osteoporosis

C. Crandall, C. Crandall, 2003, Postgraduate medicine.

Genetic evidence for causal relationships between age at natural menopause and the risk of aging-associated adverse health outcomes

T. Assimes, M. Stefanick, C. Crandall, 2022, medRxiv.

Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)

L. Habel, N. Oestreicher, F. Modugno, 2008, Breast Cancer Research and Treatment.

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy

J. Manson, R. Prentice, B. Howard, 2019, Annals of Internal Medicine.

Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation.

K. Matthews, B. Sternfeld, E. Gold, 2009, American journal of epidemiology.

Beyond frequency: who is most bothered by vasomotor symptoms?

K. Matthews, R. Hess, J. Bromberger, 2008, Menopause.

Association of breast cancer and its therapy with menopause-related symptoms

P. Ganz, G. Greendale, C. Crandall, 2004, Menopause.

Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.

S. Crawford, E. Gold, C. Crandall, 2006, The American journal of medicine.

Insulin Resistance and Bone Strength: Findings From the Study of Midlife in the United States

T. Seeman, G. Greendale, C. Crandall, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Postmenopausal weight change and incidence of fracture: post hoc findings from Women’s Health Initiative Observational Study and Clinical Trials

J. Cauley, S. Going, J. Wactawski‐Wende, 2015, BMJ : British Medical Journal.

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

L. Kuller, J. Cauley, G. Anderson, 2009, Archives of internal medicine.

Associations of menopausal vasomotor symptoms with fracture incidence.

J. Manson, A. LaCroix, J. Cauley, 2015, The Journal of clinical endocrinology and metabolism.

Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.

E. Barrett-Connor, B. Reboussin, G. Greendale, 2006, Journal of women's health.

Menopausal bone changes and incident fractures in diabetic women: a cohort study

J. Cauley, K. Sutton-Tyrrell, E. Strotmeyer, 2011, Osteoporosis International.

Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN)

K. Matthews, S. Crawford, E. Gold, 2017, Menopause.

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative

L. Carbone, J. Wactawski‐Wende, K. Johnson, 2020, JBMR plus.

Optimism, Cynical Hostility, Falls, and Fractures: The Women's Health Initiative Observational Study (WHI‐OS)

Stephen F. Smagula, J. Cauley, J. Wactawski‐Wende, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

J. Cauley, J. Wactawski‐Wende, C. Crandall, 2023, Osteoporosis International.

Cumulative Endogenous Estrogen Exposure Is Associated With Postmenopausal Fracture Risk: The Women's Health Initiative Study

J. Cauley, E. Leblanc, C. Crandall, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Association between soft drink consumption and osteoporotic fractures among postmenopausal women: the Women's Health Initiative.

A. LaCroix, C. Crandall, K. Masaki, 2019, Menopause.

Psychosocial stress and bone loss among postmenopausal women: results from the Women’s Health Initiative

Chengcheng Hu, C. Crandall, Y. Klimentidis, 2019, Journal of Epidemiology & Community Health.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

J. Manson, Karen C Johnson, R. Chlebowski, 2018, Menopause.

Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis

R. Chlebowski, P. Newcomb, C. Crandall, 2018, JNCI cancer spectrum.

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

A. LaCroix, C. Kooperberg, R. Chlebowski, 2016, Menopause.

Dietary Patterns and Fractures in Postmenopausal Women: Results From the Women's Health Initiative.

J. Cauley, L. Carbone, J. Shikany, 2016, JAMA internal medicine.

Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials

J. Manson, J. Cauley, G. Anderson, 2012, Breast Cancer Research and Treatment.

Predictors of breast discomfort among women initiating menopausal hormone therapy

G. Greendale, C. Crandall, D. Markovic, 2009, Menopause.

Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.

G. Ursin, G. Greendale, C. Crandall, 2006, Archives of internal medicine.

Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Orthopedic nursing.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Journal of orthopaedic trauma.

Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort

S. Kardia, P. Peyser, Jennifer A. Smith, 2021, Menopause.

Serum prolactin levels are positively associated with mammographic density in postmenopausal women

S. Ingles, E. Barrett-Connor, G. Ursin, 2007, Breast Cancer Research and Treatment.

Predictors of vasomotor symptoms among breast cancer survivors

M. Pennell, E. Paskett, C. Crandall, 2018, Journal of Cancer Survivorship.

Changes in serum endogenous estrogen concentrations are mediators of the effect of low-dose oral estradiol on vasomotor symptoms

K. Ensrud, S. Reed, C. Crandall, 2022, Menopause.

Update in Women's Health: Evidence Published in 2010

J. Pregler, C. Crandall, 2011, Annals of Internal Medicine.

Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women

L. Hou, Zuo-Feng Zhang, R. Chlebowski, 2017, Menopause.

Mammographic density in a multiethnic cohort

J. Cauley, B. Sternfeld, L. Habel, 2007, Menopause.

Breast tenderness after initiation of conjugated equine estrogens and mammographic density change

J. Manson, J. Cauley, G. Anderson, 2012, Breast Cancer Research and Treatment.

Physical activity and mammographic density in a cohort of midlife women.

B. Sternfeld, L. Habel, N. Oestreicher, 2008, Medicine and science in sports and exercise.

Genetic polymorphisms and obesity influence estradiol decline during the menopause

B. Nan, S. Kardia, D. McConnell, 2011, Clinical endocrinology.

Active, but not passive cigarette smoking was inversely associated with mammographic density

L. Habel, N. Oestreicher, E. Gold, 2009, Cancer Causes & Control.

The association between mammographic breast density and bone mineral density in the study of women's health across the nation.

Barbara Sternfeld, J. Cauley, B. Sternfeld, 2007, Annals of epidemiology.

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study

B. Reboussin, G. Ursin, G. Greendale, 2005, Breast Cancer Research.

Increases in Serum Estrone Sulfate Level Are Associated with Increased Mammographic Density during Menopausal Hormone Therapy

S. Ingles, E. Barrett-Connor, G. Ursin, 2008, Cancer Epidemiology Biomarkers & Prevention.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians

T. Wilt, A. Qaseem, R. Mustafa, 2019, Annals of Internal Medicine.

Pre- and Early Peri-menopausal Physical Function and Risk of Cardiovascular Events: The Study of Women’s Health Across the Nation

I. Janssen, B. Appelhans, E. Strotmeyer, 2022, Journal of aging and health.

Evidence map of ductal carcinoma in situ management options.

Kathryn E. Bouskill, P. Ganz, J. Miles, 2019, Menopause.

Dietary intake related to prevalent functional limitations in midlife women.

M. Yosef, C. Crandall, M. Jannausch, 2008, American journal of epidemiology.

Childhood socioeconomic status and adult femoral neck bone strength: findings from the Midlife in the United States Study.

T. Seeman, G. Greendale, C. Crandall, 2013, Bone.

Socioeconomic status over the life-course and adult bone mineral density: the Midlife in the U.S. Study.

T. Seeman, G. Greendale, C. Crandall, 2012, Bone.

Dietary Patterns and Fractures in Postmenopausal Women: Results From the Women's Health Initiative.

J. Cauley, L. Carbone, J. Shikany, 2016, JAMA internal medicine.

Genetic polymorphisms and obesity influence estradiol decline during the menopause

B. Nan, D. McConnell, J. Randolph, 2011, Clinical endocrinology.

Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk

Zuo-Feng Zhang, T. Rohan, C. Crandall, 2017, PloS one.

The long-term effect of intentional weight loss on changes in bone mineral density in persons with type 2 diabetes: results from the Look AHEAD randomized trial

H. Hazuda, F. Pi‐Sunyer, E. Lipkin, 2023, Archives of Osteoporosis.

Risk of Fracture in Women with Sarcopenia, Low Bone Mass, or Both

R. Wallace, K. Johnson, C. Crandall, 2017, Journal of the American Geriatrics Society.

Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study.

J. Cauley, G. Greendale, C. Crandall, 2012, The Journal of clinical endocrinology and metabolism.

Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures

P. Shekelle, Y. Lim, W. Gellad, 2020 .

Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures

P. Shekelle, Y. Lim, W. Gellad, 2014, Annals of Internal Medicine.

Population-Based Osteoporosis Primary Prevention and Screening for Quality of Care in Osteoporosis, Current Osteoporosis Reports

W. Leslie, C. Crandall, C. Crandall, 2019, Current Osteoporosis Reports.

Socioeconomic status in relation to incident fracture risk in the Study of Women’s Health Across the Nation

T. Seeman, G. Greendale, C. Crandall, 2014, Osteoporosis International.

Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation

K. Matthews, B. Sternfeld, K. Sutton-Tyrrell, 2011, Menopause.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

J. Manson, Karen C Johnson, R. Chlebowski, 2018, Menopause.

Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

T. Seeman, G. Greendale, A. Karlamangla, 2014, The Journal of clinical endocrinology and metabolism.

Multi-System Dysregulation and Bone Strength : Findings from the Study of Midlife in the Unites States

T. Seeman, G. Greendale, C. Crandall, 2014 .

Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial

J. Manson, J. Cauley, J. Wactawski‐Wende, 2016, Menopause.

Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI)

C. Cooper, J. Kanis, L. Carbone, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan

C. Crandall, D. Ganz, Takahiro Mori, 2021, Archives of Osteoporosis.

C‐Reactive Protein, Bone Strength, and Nine‐Year Fracture Risk: Data From the Study of Women's Health Across the Nation (SWAN)

J. Cauley, Y. Ouchi, G. Greendale, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

G. Greendale, C. Crandall, A. Karlamangla, 2016, The Journal of clinical endocrinology and metabolism.

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan

C. Crandall, D. Ganz, Takahiro Mori, 2021, Archives of Osteoporosis.

Physical Functioning Among Women Aged 80 Years and Older With Previous Fracture.

C. Lewis, J. Cauley, J. Robbins, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Estrogen replacement therapy and colon cancer: a clinical review.

C. Crandall, C. Crandall, 1999, Journal of women's health & gender-based medicine.

Development of a comprehensive health-risk prediction tool for postmenopausal women

Jennifer G. Robinson, J. Cauley, H. Hedlin, 2019, Menopause.

Parity, lactation, bone strength, and 16-year fracture risk in adult women: findings from the Study of Women's Health Across the Nation (SWAN).

J. Cauley, G. Greendale, C. Crandall, 2015, Bone.

Fracture risk assessment without race/ethnicity information.

J. Cauley, G. Greendale, C. Crandall, 2012, The Journal of clinical endocrinology and metabolism.

Gene testing to predict tamoxifen-induced hot flashes: new biological insights.

C. Crandall, C. Crandall, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Osteoporosis Screening in Younger Postmenopausal Women.

K. Ensrud, C. Crandall, C. Crandall, 2020, JAMA.

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials

J. Kanis, J. Cauley, E. McCloskey, 2022, Osteoporosis International.

Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study

J. Manson, R. Prentice, J. Cauley, 2017, Menopause.

No Increase in Fractures After Stopping Hormone Therapy: Results From the Women’s Health Initiative

J. Manson, A. LaCroix, C. Lewis, 2016, The Journal of clinical endocrinology and metabolism.

Women’s Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy

J. Manson, C. Lewis, L. Carbone, 2014, Menopause.

Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study

S. Ingles, D. J. Van Den Berg, G. Ursin, 2012, Menopause.

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

L. Kuller, J. Cauley, G. Anderson, 2009, Archives of internal medicine.

Update in Women's Health

C. Crandall, J. Pregler, C. Crandall, 2005, Annals of Internal Medicine.

Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor symptoms but not negative mood in the early perimenopausal transition: Study of Women's Health Across the Nation.

S. Crawford, C. Derby, E. Gold, 2021, Maturitas.

Association of Menopausal Vasomotor Symptoms With Increased Bone Turnover During the Menopausal Transition

S. Crawford, C. Tseng, E. Gold, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing

J. Cauley, K. Ensrud, B. Taylor, 2017, Journal of General Internal Medicine.

Performance of FRAX and FRAX‐Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry

L. Lix, W. Leslie, J. Schousboe, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Who should be screened for osteoporosis?

K. Ensrud, C. Crandall, C. Crandall, 2021, Marcus and Feldman's Osteoporosis.

American Journal of Epidemiology Original Contribution Gains in Body Fat and Vasomotor Symptom Reporting over the Menopausal Transition the Study of Women's Health across the Nation

B. Sternfeld, E. Gold, J. Bromberger, 2022 .

Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma.

Ivana V. Yang, Andrew D. Johnson, Benjamin D. Heavner, 2019, Chest.

Vitamin A intake and osteoporosis: a clinical review.

C. Crandall, C. Crandall, 2004, Journal of women's health.

Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report

P. Shekelle, Y. Lim, W. Gellad, 2012 .

Bone Health During the Menopause Transition and Beyond.

C. Crandall, A. Karlamangla, S. M. Burnett-Bowie, 2018, Obstetrics and gynecology clinics of North America.